Literature DB >> 2864615

Systemic complications of intravesical BCG therapy for bladder cancer.

A Steg, D Sicard, C Leleu, B Debré, L Boccon-Gibod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2864615     DOI： 10.1016/s0140-6736(85)90169-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Macrophage-inducible C-type lectin Mincle-expressing dendritic cells contribute to control of splenic Mycobacterium bovis BCG infection in mice.

Authors:  Friederike Behler; Regina Maus; Jennifer Bohling; Sarah Knippenberg; Gabriele Kirchhof; Masahiro Nagata; Danny Jonigk; Nicole Izykowski; Lavinia Mägel; Tobias Welte; Sho Yamasaki; Ulrich A Maus
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

Review 2.  Invasive bladder cancer--possible future treatment considerations.

Authors:  R A Gardiner
Journal:  Urol Res       Date:  1986

3.  Pulmonary disease following intravesical BCG treatment.

Authors:  S Kesten; L Title; B Mullen; R Grossman
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

4.  Complications of intravesical bacillus calmette-guérin.

Authors:  Liam C Macleod; Tin C Ngo; Mark L Gonzalgo
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.